Developing a scaffold for urease inhibition based on benzothiazoles: Synthesis, docking analysis, and therapeutic potential
作者:Musa Özil、Özge Tuzcuoğlu、Mustafa Emirik、Nimet Baltaş
DOI:10.1002/ardp.202100200
日期:2021.12
The synthesis, in silico molecular docking, and in vitro urease inhibition studies of a novel series of benzothiazole derivatives are reported. The title compounds in the two series, namely, 2-(5-[(benzothiazol-2-ylthio)methyl]-1,3,4-oxadiazol-2-yl}thio)-1-(4-substituted-phenyl)ethan-1-one and 2-(benzothiazol-2-ylthio)-1-(4-substituted-phenyl)ethan-1-one oxime, were synthesized by the reaction of
报告了一系列新型苯并噻唑衍生物的合成、计算机分子对接和体外脲酶抑制研究。两个系列的标题化合物,即2-(5-[(苯并噻唑-2-基硫基)甲基]-1,3,4-恶二唑-2-基}硫基)-1-(4-取代-苯基)ethan-1-one 和 2-(benzothiazol-2-ylthio)-1-(4-取代苯基)ethan-1-one 肟,由苯并[ d ]thiazole-2-thiol 与不同的使用常规和微波技术在几个步骤中获得各种中间体。与 IC 50的标准抑制剂乙酰氧肟酸相比,所有化合物均具有出色的脲酶抑制潜力,范围在 16.16 ± 0.54 和 105.32 ± 2.10 µM 之间 = 320.70 ± 4.24 µM。详细建立了构效关系。通过分子对接证实了化合物与酶的结合相互作用。此外,进行了 100 纳秒的分子动力学模拟,以研究最有效的化合物在脲酶活性位点上所经历的稳定性和结构扰动。